Company intelligence / Profile preview

International Science

Ownership: Private
Development stage: Other

Overview

International Science is a biotechnology company focused on the development of novel therapeutic solutions for metabolic disorders and oncology. The company leverages its expertise in molecular biology and pharmacology to identify and optimize drug candidates that address significant unmet medical needs. Currently, International Science is primarily engaged in pre-clinical research, aiming to advance its lead programs toward clinical trials. Their approach combines traditional drug discovery methods with innovative screening technologies to accelerate the development of effective treatments.

Therapeutic areas: OncologyMetabolic Disorders
Modalities: Small moleculePeptides
Industry: Biotech

Beyond the preview

Go deeper on International Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on International Science.

Explore the full profile